Univariate analysis to predict number of collected CD34 cells equaling or exceeding 2 × 106/kg after first mobilization
Variables . | Results . | P . |
|---|---|---|
| Age, y | 53.5 (38-66) | .73 |
| Male-female ratio | 33/5 | .57 |
| Initial Binet (B/C) stage before FDR-CY | 34/4 | .51 |
| Blood count at presentation before FDR-CY | ||
| Hemoglobin, g/L | 135.0 (100.0-170.0) | .17 |
| Lymphocytes, × 109/L | 45.5 (5.0-286.0) | .99 |
| Neutrophils, × 109/L | 4.3 (0.0-21.0) | .77 |
| Platelets, × 109/L | 183.5 (57.0-279.0) | .42 |
| No. FuCy courses (c)* | 6c (n = 34); 5c (n = 2); 4c (n = 1); 2c (n = 1) | .51 |
| Disease status at evaluation after FDR-CY: PR/CR | 12/26 | .63 |
| Blood count at evaluation, 2 mo after last FDR-CY c* | ||
| Hemoglobin, g/L | 137.5 (73.0-156.0) | .64 |
| Lymphocytes, × 109/L | 0.7 (0.1-1.7) | .30 |
| Neutrophils, × 109/L | 2.9 (0.9-8.0) | .11 |
| Platelets, × 109/L | 178.0 (50.0-330.0) | .052 |
| Interval from last FDR-CY c to mobilization, d | 178.0 (69-377) | .19 |
| Mobilization: filgrastim/lenograstim | 25/13 | .67 |
| Blood count immediately before mobilization* | ||
| Hemoglobin, g/L | 142.0 (95.0-163.0) | .56 |
| Leukocytes, × 109/L | 4.3 (2.1-11.4) | .097 |
| Neutrophils, × 109/L | 2.8 (1.1-8.7) | .085 |
| Lymphocytes, × 109/L | 0.8 (0.2-5.4) | .96 |
| Monocytes, × 109/L | 0.3 (0.1-0.8) | .20 |
| Platelets, × 109/L | 177.5 (86.0-461.0) | .009 |
Variables . | Results . | P . |
|---|---|---|
| Age, y | 53.5 (38-66) | .73 |
| Male-female ratio | 33/5 | .57 |
| Initial Binet (B/C) stage before FDR-CY | 34/4 | .51 |
| Blood count at presentation before FDR-CY | ||
| Hemoglobin, g/L | 135.0 (100.0-170.0) | .17 |
| Lymphocytes, × 109/L | 45.5 (5.0-286.0) | .99 |
| Neutrophils, × 109/L | 4.3 (0.0-21.0) | .77 |
| Platelets, × 109/L | 183.5 (57.0-279.0) | .42 |
| No. FuCy courses (c)* | 6c (n = 34); 5c (n = 2); 4c (n = 1); 2c (n = 1) | .51 |
| Disease status at evaluation after FDR-CY: PR/CR | 12/26 | .63 |
| Blood count at evaluation, 2 mo after last FDR-CY c* | ||
| Hemoglobin, g/L | 137.5 (73.0-156.0) | .64 |
| Lymphocytes, × 109/L | 0.7 (0.1-1.7) | .30 |
| Neutrophils, × 109/L | 2.9 (0.9-8.0) | .11 |
| Platelets, × 109/L | 178.0 (50.0-330.0) | .052 |
| Interval from last FDR-CY c to mobilization, d | 178.0 (69-377) | .19 |
| Mobilization: filgrastim/lenograstim | 25/13 | .67 |
| Blood count immediately before mobilization* | ||
| Hemoglobin, g/L | 142.0 (95.0-163.0) | .56 |
| Leukocytes, × 109/L | 4.3 (2.1-11.4) | .097 |
| Neutrophils, × 109/L | 2.8 (1.1-8.7) | .085 |
| Lymphocytes, × 109/L | 0.8 (0.2-5.4) | .96 |
| Monocytes, × 109/L | 0.3 (0.1-0.8) | .20 |
| Platelets, × 109/L | 177.5 (86.0-461.0) | .009 |
Variables were demographic, clinical, and biologic characteristics of 38 B-CLL patients. All numbers in parentheses are ranges, and all numbers preceding them are medians.
Continuous variables.